These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 15256110

  • 1. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 2. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS, Teng XD, Ding W, Zhou J, Yao HT, Ying LX, Xu LM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
    Park YJ, Kwak SH, Kim DC, Kim H, Choe G, Park DJ, Jang HC, Park SH, Cho BY, Park SY.
    J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
    [Abstract] [Full Text] [Related]

  • 6. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN, He L, Cheng JQ, Chen SC, Zhao HF, Zhai JP, Zhang J.
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [Abstract] [Full Text] [Related]

  • 7. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA, Hussein MRA, Osman MH, Mohamed GA, Hosny G.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3365-3376. PubMed ID: 34711014
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS.
    Histopathology; 2005 Oct 01; 47(4):391-401. PubMed ID: 16178894
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR, Gucer H.
    Pol J Pathol; 2017 Oct 01; 68(1):1-10. PubMed ID: 28547974
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules.
    Cui W, Sang W, Zheng S, Ma Y, Liu X, Zhang W.
    Clin Lab; 2012 Oct 01; 58(7-8):673-80. PubMed ID: 22997967
    [Abstract] [Full Text] [Related]

  • 11. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
    Saleh HA, Jin B, Barnwell J, Alzohaili O.
    Diagn Pathol; 2010 Jan 26; 5():9. PubMed ID: 20181018
    [Abstract] [Full Text] [Related]

  • 12. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern].
    Laco J, Ryska A.
    Cesk Patol; 2006 Jul 26; 42(3):120-4. PubMed ID: 16955558
    [Abstract] [Full Text] [Related]

  • 13. Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
    Mataraci EA, Ozgüven BY, Kabukçuoglu F.
    Pol J Pathol; 2012 Mar 26; 63(1):58-64. PubMed ID: 22535608
    [Abstract] [Full Text] [Related]

  • 14. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr 26; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 15. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep 26; 27(9):547-50. PubMed ID: 16438854
    [Abstract] [Full Text] [Related]

  • 16. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
    Liu YY, Morreau H, Kievit J, Romijn JA, Carrasco N, Smit JW.
    Eur J Endocrinol; 2008 Mar 26; 158(3):375-84. PubMed ID: 18299472
    [Abstract] [Full Text] [Related]

  • 17. Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions.
    Palo S, Biligi DS.
    Malays J Pathol; 2017 Apr 26; 39(1):55-67. PubMed ID: 28413206
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].
    Bogdańska M, Górnicka B, Ziarkiewicz-Wróblewska B, Koperski L, Morton M, Wasiutyński A.
    Endokrynol Pol; 2006 Apr 26; 57(4):314-9. PubMed ID: 17006830
    [Abstract] [Full Text] [Related]

  • 19. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
    Torregrossa L, Faviana P, Filice ME, Materazzi G, Miccoli P, Vitti P, Fontanini G, Melillo RM, Santoro M, Basolo F.
    Thyroid; 2010 May 26; 20(5):495-504. PubMed ID: 20450430
    [Abstract] [Full Text] [Related]

  • 20. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.
    Singapore Med J; 2008 Apr 26; 49(4):333-8. PubMed ID: 18418527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.